Skip to main content

Advertisement

SpringerLink
Log in

Plasma Replacement Therapy for Alzheimer’s Disease

  • RESEARCH HIGHLIGHT
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Patterson, C. World Alzheimer Report 2018. The state of the art of dementia research: new frontiers. An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International 2018.

  2. Sun BL, Li WW, Zhu C, Jin WS, Zeng F, Liu YH, et al. Clinical research on Alzheimer’s disease: progress and perspectives. Neurosci Bull 2018, 34: 1111–1118.

    Article  CAS  Google Scholar 

  3. Sha SJ, Deutsch GK, Tian L, Richardson K, Coburn M, Gaudioso JL, et al. Safety, Tolerability, and feasibility of young plasma infusion in the plasma for Alzheimer symptom amelioration study: a randomized clinical trial. JAMA Neurol 2019, 76: 35–40.

    Article  Google Scholar 

  4. Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 2014, 20: 659–663.

    Article  CAS  Google Scholar 

  5. Castellano JM, Mosher KI, Abbey RJ, McBride AA, James ML, Berdnik D, et al. Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 2017, 544: 488–492.

    Article  CAS  Google Scholar 

  6. Boada M, Anaya F, Ortiz P, Olazaran J, Shua-Haim JR, Obisesan TO, et al. Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-beta concentrations and cognition outcomes in Alzheimer’s disease patients: a multicenter, randomized, controlled clinical trial. J Alzheimers Dis 2017, 56: 129–143.

    Article  CAS  Google Scholar 

  7. Ramos-Fernandez E, Tajes M, Palomer E, Ill-Raga G, Bosch-Morato M, Guivernau B, et al. Posttranslational nitro-glycative modifications of albumin in Alzheimer’s disease: implications in cytotoxicity and amyloid-beta peptide aggregation. J Alzheimers Dis 2014, 40: 643–657.

    Article  CAS  Google Scholar 

  8. Costa M, Horrillo R, Ortiz AM, Perez A, Mestre A, Ruiz A, et al. Increased Albumin oxidation in cerebrospinal fluid and plasma from Alzheimer’s disease patients. J Alzheimers Dis 2018, 63: 1395–1404.

    Article  CAS  Google Scholar 

  9. Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, et al. Blood-derived amyloid-beta protein induces Alzheimer’s disease pathologies. Mol Psychiatry 2018, 23: 1948–1956.

    Article  Google Scholar 

  10. Jin WS, Shen LL, Bu XL, Zhang WW, Chen SH, Huang ZL, et al. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model. Acta Neuropathol 2017, 134: 207–220.

    Article  CAS  Google Scholar 

  11. Yu Q, Zhong C. Membrane aging as the real culprit of Alzheimer’s disease: modification of a hypothesis. Neurosci Bull 2018, 34: 369–381.

    Article  CAS  Google Scholar 

  12. Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB. What is normal in normal aging? Effects of aging, amyloid and Alzheimer’s disease on the cerebral cortex and the hippocampus. Prog Neurobiol 2014, 117: 20–40.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This highlight was supported by the National Natural Science Foundation of China (81722016), and the R&D Infrastructure and Facility Development Program of Sichuan Province, China (2018TJPT0037).

Author information

Authors and Affiliations

  1. Department of Neurology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China

    Xu-long Ding & Peng Lei

  2. West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, 610041, China

    Xu-long Ding & Peng Lei

  3. Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China

    Xu-long Ding & Peng Lei

Authors
  1. Xu-long Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peng Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peng Lei.

Ethics declarations

Conflict of interest

The authors declare no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ding, Xl., Lei, P. Plasma Replacement Therapy for Alzheimer’s Disease. Neurosci. Bull. 36, 89–90 (2020). https://doi.org/10.1007/s12264-019-00394-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-019-00394-5

Search

Navigation